已收盘 08-15 16:00:00 美东时间
-0.020
-0.72%
Firefly Neuroscience (NASDAQ:AIFF) reported quarterly losses of $(0.14) per share. This is a 41.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported $299.000 thousand
08-14 05:09
Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and
07-14 19:47
Firefly Neuroscience与海德堡大学医院合作,开展关于15q13.3 CNVs的EEG生物标志物研究,旨在揭示罕见遗传条件下的脑功能架构,支持诊断和治疗,计划于2026年完成。
07-14 11:45
TradingKey - 因OpenAI联合创始人Greg Brockman转发了一条帖子,AI医疗再一次进入公众视野并引起热议。
07-07 10:22
Firefly Neuroscience, Inc. has been added to the Russell Microcap® Index, reflecting significant progress since its Nasdaq listing less than a year ago. Firefly has made breakthroughs including a cognitive brain age biomarker discovery, joining NVIDIA Connect, expanding through the acquisition of Evoke Neuroscience, and developing a new method to distinguish between cognitive decline stages. CEO Greg Lipschitz emphasizes enhanced visibility for i...
06-23 12:05
Firefly Neuroscience shares are trading higher after the company. announced a b...
06-20 20:57
A study published by Firefly Neuroscience highlights the effectiveness of combining EEG/ERP and vMRI for accurately distinguishing between subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia. The research, involving real-world data from memory clinic patients, found that using three EEG measures—reaction time, commission errors, and P300b amplitude—could categorize subjects with 80% accuracy. Adding vMRI data, partic...
06-20 11:45
Firefly Neuroscience ( ($AIFF) ) has shared an update. On June 16, 2025, Firefl...
06-17 04:51
Firefly Neuroscience (NASDAQ:AIFF) reported quarterly losses of $(1.74) per share. This is a 690.91 percent decrease over losses of $(0.22) per share from the same period last year. The company reported $43.00 thousand
05-14 21:52
Gainers Akebia Therapeutics (NASDAQ:AKBA) shares rose 31.6% to $2.23 during Fr...
03-15 01:05